https://www.avient.com/knowledge-base/article/securing-supplies-medical-plastic-solutions?pname[]=17815
Mevopur™ Healthcare Colorants and Formulations
Mevopur™ Healthcare Functional Additives
Mevopur™ Healthcare Functional Additives
https://www.avient.com/investor-center/news/avient-announces-third-quarter-2020-results
In millions, except per share data)
In millions, except per share data)
Condensed Consolidated Balance Sheets
https://www.avient.com/investor-center/news/avient-announces-record-second-quarter-2021-results-increases-full-year-guidance
Condensed Consolidated Balance Sheets
(In millions)
Clariant MB
Clariant MB
https://www.avient.com/sites/default/files/2021-04/avnt-fourth-quarter-2020-news-release.pdf
This represents a 45% increase over the prior
year quarter, pro forma for the Clariant Masterbatch business.”
The Company highlighted that integration of the Clariant Masterbatch business is continuing to
exceed expectations.
See Attachment 3 for a definition and summary of special items and Attachment 7 for a summary of pro forma adjustments
associated with the Clariant MB Acquisition necessary to reflect Clariant MB adjusted results in all periods presented.
https://www.avient.com/resources/safety-data-sheets?page=6879
Avient has transitioned our Material Safety Data Sheets (MSDSs) to Safety Data Sheets (SDSs) for our manufactured products to meet the requirements of the Globally Harmonized System of Classification and Labeling of Chemicals (GHS), and CLP classification in Europe.
Technical Data Sheets
Safety Data Sheets
https://www.avient.com/resources/safety-data-sheets?page=7136
Avient has transitioned our Material Safety Data Sheets (MSDSs) to Safety Data Sheets (SDSs) for our manufactured products to meet the requirements of the Globally Harmonized System of Classification and Labeling of Chemicals (GHS), and CLP classification in Europe.
Technical Data Sheets
Safety Data Sheets
https://www.avient.com/sites/default/files/2022-04/Avient Acquisition of Dyneema and Q1 2022 Results_0.pdf
Avient acquired the Clariant Color business on July 1, 2020 (the “Acquisition Date”).
To provide comparable financial results, the Company references “pro forma” financial metrics, which include the business results of Clariant Color for
periods prior to the Acquisition Date.
As
presented in previous slides, this presents potential benefits with
respect to leverage and EBITDA margins
Reconciliation of Non-GAAP Financial Measures
(Unaudited)
(Dollars in millions, except for per share data)
Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders
and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special
items, to assess performance and facilitate comparability of results.
https://www.avient.com/sites/default/files/2022-04/MEVOPUR LQ for Silicone Elastomers.pdf
MEVOPUR™ LQ
Liquid Color & Additive Concentrates for Silicone Elastomers
Silicones elastomers are materials of choice in a
wide range of medical applications because of the
combination of unique physical properties such
as strength, durability, and flexibility combined
with one of the most tested polymers in terms of
biocompatibility and hypo-allergenic properties.
The MEVOPUR™ LQ advanced range of liquid color
& additive concentrates utilize the specific liquid
carrier system designed for high compatibility
with silicone elastomers.
Customized color solutions are
available on request
• Production under ISO 13485 / GMP quality
system with change control management
• Fingerprinting of raw materials and routine
batch testing
• Extractability evaluated in hexane, isopropanol,
and water according
to ISO 10993 part 18
REGULATORY SUPPORT
• Raw materials are pre-tested to biologically-
evaluated raw materials using ISO 10993-1 and
USP chapters , Class VI
• DMF/MAF documentation filed with the FDA
for all standard colors
APPLICATIONS
MEVOPUR LQ formulations can be applied
in demanding applications including:
• Medical devices such as catheter tubing
& connectors, syringe tips, and needleless
connectors
• Skin contact devices such as wearables
or soft-touch surfaces of medical devices
PRODUCT BULLETIN
MEVOPUR™-LQ YELLOW (PMS1205C)
Product Code FZ1M415005
MEVOPUR™-LQ TRANS YELLOW
Product Code FZ1M415006
MEVOPUR™-LQ BLUE (PMS292C)
Product Code FZ5M415008
MEVOPUR™-LQ TRANS BLUE
Product Code FZ5M415009
MEVOPUR™-LQ RED (PMS198C)
Product Code FZ3M415008
MEVOPUR™-LQ TRANS RED
Product Code FZ3M415009
MEVOPUR™-LQ GREEN (PMS346C)
Product Code FZ6M415008
MEVOPUR™-LQ TRANS GREEN
Product Code FZ6M415009
MEVOPUR™-LQ VIOLET (PMS2655C)
Product Code FZ4M415003
MEVOPUR™-LQ TRANS VIOLET
Product Code FZ4M415004
CUSTOM-MADE Individual options
Customized colors
are also available to
meet your needs,
please contact us.
https://www.avient.com/investor-center/news/avient-announces-record-first-quarter-2021-results-increases-full-year-guidance
In millions, except per share data)
In millions, except per share data)
Condensed Consolidated Balance Sheets
https://www.avient.com/sites/default/files/2023-05/Mevopur Amber for PET Pharma Pkg Application Bulletin_CN _2.pdf
MEVOPUR Amber for PET Pharma Pkg Application Bulletin_CN5.12-1
* 可根据要求提供
FDA/EU合规信息
应用公告
Mevopur™应用于药品包装的 医疗级琥珀色系着色剂和配方
埃万特时刻关注着医疗保健行业法规的演变,并
提前在这些法规生效之前开发合规产品。
经预测
试的琥珀色着色剂是Mevopur™产品组合中的一
员,可应用于PET药水瓶、瓶子和其他包装产
品。
我们公布了埃万特的Mevopur™产品政策和使用限制,以帮助客户选择产品,同时践行我们的承诺。